SPP1, secreted phosphoprotein 1, 6696

N. diseases: 824; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020503
Disease: Hyperparathyroidism, Secondary
Hyperparathyroidism, Secondary
0.010 Biomarker disease BEFREE In this study, we investigated the effects of oral treatment with paricalcitol, a potent vitamin D receptor activator, on arterial stiffness and osteopontin, a marker of atherosclerosis, in hypertensive patients with chronic kidney disease (CKD) and secondary hyperparathyroidism. 29305902 2020
CUI: C0242490
Disease: Enthesopathy
Enthesopathy
0.010 GeneticVariation disease BEFREE Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy? 31843680 2020
CUI: C0578575
Disease: Dissection of proximal aorta
Dissection of proximal aorta
0.010 Biomarker disease BEFREE ROC analysis showed that OPN could be indicators for TAAD diagnosis with sensitivity of 0.92 and specificity of 0.99. 31786503 2020
CUI: C0867389
Disease: Chronic graft-versus-host disease
Chronic graft-versus-host disease
0.010 Biomarker disease BEFREE Analysis focused on previously identified cGVHD cellular biomarkers, including naive helper T (Th) cells, recent thymic emigrant (RTE) Th cells, CD21<sup>low</sup> B cells, CD56<sup>bright</sup> NK<sub>reg</sub> cells, and T<sub>reg</sub> cells ST2, osteopontin, sBAFF, sCD25, TIM-3, matrix metallopeptidase 3, ICAM-1, CXCL10, and soluble aminopeptidase N. The ATG-treated group had a >10-fold decrease in both RTE naive Th and naive Th cells (P < .0001) and a 10-fold increase in CD56<sup>bright</sup> NK<sub>reg</sub> cells (P < .0001). 31756535 2020
CUI: C1306587
Disease: Acute encephalopathy
Acute encephalopathy
0.010 AlteredExpression disease BEFREE The CSF:serum ratios of OPN, CC chemokine ligand (CCL)4, and interleukin (IL)-10 were significantly higher in AE than in FC. 31787380 2020
Nonrheumatic aortic (valve) stenosis
0.010 AlteredExpression disease BEFREE This study compared smooth muscle α-actin (α-SMA), osteopontin (OPN), and suppression of tumorigenicity 2 (ST2) expression between specimens from fibrotic and calcific stages of NR-AS and observed the effects and mechanisms of phenotypic transition of porcine valvular interstitial cells (VICs) in the presence of IL-33. 31416779 2020
CUI: C0001306
Disease: Acute alcoholic liver disease
Acute alcoholic liver disease
0.010 Biomarker disease BEFREE Conclusion: Our study suggests that sCD14, LBP, OPN, sCD163, and sCD206 are biomarkers to indicate severity and predict clinical outcomes in AH. 30891779 2019
Congenital arteriovenous malformation
0.010 AlteredExpression disease BEFREE Expression of osteopontin, matrix metalloproteinase-2 and -9 proteins in vascular instability in brain arteriovenous malformation. 31275742 2019
CUI: C0005967
Disease: Bone neoplasms
Bone neoplasms
0.010 Biomarker group BEFREE A subpopulation of osteoblasts was identified in the bone tumor microenvironment in vivo of both humans and mice with bone metastatic breast cancer that express RUNX2/OCN/OPN but is negative for IL-6 and alpha-smooth muscle actin. 30813947 2019
CUI: C0013743
Disease: Eisenmenger Complex
Eisenmenger Complex
0.010 Biomarker disease BEFREE Our results showed that OPN was increased in lungs and plasma of patients with Eisenmenger syndrome; moreover, OPN and α<sub>V</sub>β<sub>3</sub>-integrin expression levels were augmented in rat lungs exposed to systemic-to-pulmonary shunt. 30893567 2019
CUI: C0014647
Disease: Giant Cell Epulis
Giant Cell Epulis
0.010 Biomarker disease BEFREE In this retrospective study, the presence of matrix metalloproteinases-2 and osteopontin in 37 cases of central giant cell granuloma and 37 cases of peripheral giant cell granuloma paraffin blocks were assessed by streptavidin-biotin immunohistochemistry. 29339027 2019
CUI: C0017605
Disease: Angle Closure Glaucoma
Angle Closure Glaucoma
0.010 AlteredExpression disease BEFREE We assume that elevated levels of OPN and cystatin C in POAG and PACG along with altered cathepsin levels may contribute to ECM aberration in glaucoma. 30994369 2019
CUI: C0017606
Disease: Primary angle-closure glaucoma
Primary angle-closure glaucoma
0.010 AlteredExpression disease BEFREE We assume that elevated levels of OPN and cystatin C in POAG and PACG along with altered cathepsin levels may contribute to ECM aberration in glaucoma. 30994369 2019
CUI: C0019829
Disease: Hodgkin Disease
Hodgkin Disease
0.010 AlteredExpression disease BEFREE Serum osteopontin level is associated with heart valve calcification in HD patients, but there was no relationship found with FGF-23. 30369401 2019
CUI: C0020179
Disease: Huntington Disease
Huntington Disease
0.010 AlteredExpression disease BEFREE Serum osteopontin level is associated with heart valve calcification in HD patients, but there was no relationship found with FGF-23. 30369401 2019
CUI: C0023281
Disease: Leishmaniasis
Leishmaniasis
0.010 Biomarker disease BEFREE OPN, further evaluated as a target for Leishmaniasis control represents an additional interest in improving vaccination strategies against the parasites. 30736736 2019
CUI: C0023798
Disease: Lipoma
Lipoma
0.010 AlteredExpression disease BEFREE The expression of OPN and CA9 was exclusively upregulated in the ASCs of LP. 31640774 2019
CUI: C0029401
Disease: Osteitis Deformans
Osteitis Deformans
0.010 AlteredExpression disease BEFREE Patients with PDB presented higher levels of osteopontin and RANKL. 31384515 2019
CUI: C0030807
Disease: Pemphigus
Pemphigus
0.010 Biomarker disease BEFREE The growth observed in OPN levels in pemphigus patients suggests the role of OPN in pemphigus pathogenesis, but there is a need for more extensive studies to show how OPN can be associated with the PV pathogenesis and whether OPN could be used as an important therapeutic target in pemphigus disease. 31136685 2019
CUI: C0030809
Disease: Pemphigus Vulgaris
Pemphigus Vulgaris
0.010 Biomarker disease BEFREE However, the role of OPN in PV has not been well studied so far. 31136685 2019
CUI: C0032269
Disease: Pneumococcal Infections
Pneumococcal Infections
0.010 Biomarker group BEFREE This study aimed to investigate whether OPN affects inflammation and vulnerability to pneumococcal infection in atopic asthma. 30362569 2019
CUI: C0152021
Disease: Congenital heart disease
Congenital heart disease
0.010 Biomarker group BEFREE Recent studies indicated that osteopontin (OPN) was involved in the genesis and progression of pulmonary arterial hypertension (PAH); however, its role in congenital heart disease-associated PAH (CHD/PAH) remains unknown. 30893567 2019
CUI: C0155877
Disease: Allergic asthma
Allergic asthma
0.010 AlteredExpression disease BEFREE Both allergen challenge in individuals with allergic asthma and the intranasal instillation of HDM in mice resulted in increased OPN levels in bronchoalveolar lavage fluid (BALF). 30362569 2019
CUI: C0162375
Disease: Granuloma, Giant Cell Reparative
Granuloma, Giant Cell Reparative
0.010 Biomarker disease BEFREE In this retrospective study, the presence of matrix metalloproteinases-2 and osteopontin in 37 cases of central giant cell granuloma and 37 cases of peripheral giant cell granuloma paraffin blocks were assessed by streptavidin-biotin immunohistochemistry. 29339027 2019
Metastatic malignant neoplasm to brain
0.010 Biomarker disease BEFREE Therapeutic effect of combined hyperbaric oxygen and radiation therapy for single brain metastasis and its influence on osteopontin and MMP-9. 30651823 2019